A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma

NCT01890161 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Asthma

Interventions

DRUG: AXP1275
DRUG: AXP1275 matching placebo

Sponsor

Axikin Pharmaceuticals, Inc.